Quantitative MRI for Myelofibrosis

Recruiting now

Conditions studied: Myelofibrosis

In brief

This study is for the development and validation of functional magnetic resonance imaging (MRI) parameters as biomarkers for analyzing extent of disease and quantifying response to treatment in patients with myelofibrosis.

Key facts

Study ID

NCT01973881

Run by

University of Michigan Rogel Cancer Center

People needed

192

Starts

2014-12-22

Expected to finish

2026-12-01

Last updated by the study team

2026-07-31

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male /female subjects over the age of 18
• Diagnosis of primary myelofibrosis, post-polycythemia vera myelofibrosis, or post-essential thrombocythemia myelofibrosis.
• No contraindications to MRI
• Able to undergo MRI without anesthesia

You may not qualify if…

• Patients with pacemakers or other implanted magnetic devices that may malfunction or move because of the strong magnetic field inside the MRI room and scanner.
• Any prior adverse event associated with MRI that is not related to injection of contrast agents or other medicines.

Where it is running

• University of Michigan Hospital — Ann Arbor, Michigan, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.